Skip to main content
. 2015 Jul 31;50(7):595–602. doi: 10.1310/hpj5007-595

Table 2. Patient characteristics: DRP versus non-DRP.

Baseline characteristics DRP (n = 64) Non-DRP (n = 36) P
Mean age ± SD, years 58.1 ± 16.8 52.6 ± 19.5 .16
Male 35 (55) 16 (46) .44
White 35 (55) 20 (56) .93
Insured 61 (95) 35 (97) .63
Married 33 (52) 16 (44) .64
Employed 19 (30) 11 (31) .93
Comorbidities, median [Q1-Q3] 5 [3-6] 5 [3-6.75] .87
 1-3 comorbidities 17 (27) 12 (33) .63
 4-7 comorbidities 41 (64) 22 (61) .94
 ≥8 comorbidities 6 (9) 2 (6) .77

Factors regarding index admission, median [Q1-Q3]
Length of stay, days 6 [4-9] 6 [4-11] .67
Days to readmission 17 [7-34] 23 [14-43] .11
No. of medications at admission 9.5 [6-14] 10 [6-15] .48
No. of medications at discharge 12.5 [8-15] 12.5 [9-20] .48
No. of new medications at discharge 2 [0-4] 2.5 [1-4] .63
No. of total medication changes at discharge 4 [2-7] 4 [2-7] .72

Type of pharmacist involvement at index admission
Medication history by RPh 31 (48) 23 (64) .20
Pharmacy consults 17 (27) 17 (47) .06
New medications counselling 14 (22) 9 (25) .91
RPh on primary team 8 (13) 7 (19) .52
Discharge counselling 5 (8) 3 (8) .93

Factors regarding readmission
Medication history by RPh 41 (64) 20 (55) .53
Readmissions before scheduled outpatient follow-up 24 (38) 8 (22) .27
Days to readmission, median [Q1-Q3] 17 [7-34] 23 [14-43] .11
No. of total admissions during study period, median [Q1-Q3] 3 [1-4] 3 [2-4] .42

Note: Values given as n (%) unless otherwise indicated. DRP = drug-related problem; RPh = registered pharmacist.